ABSTRACT
Lysophosphatidic acid (LPA) is a simple phospholipid, and extracellular LPA has been shown to activate second messenger pathways to elicit diverse cellular responses in many types of cells (1) (2) (3) (4) (5) (6) (7) . Although nonreceptor mechanisms resulting from its perturbation of the cell membrane may contribute, LPA appears to exert its major effects through a specific cell surface receptor coupled to guanine nucleotide regulatory (G) proteins that activate pertussis toxin (PTX)-sensitive and -insensitive pathways. The PTX-sensitive pathway uses G i and inhibits adenylyl cyclase (1) . In addition, transcriptional activation of immediateearly genes, subsequent DNA synthesis, and cell proliferation appear to be mediated by activation of the G i -p21 ras -mitogenactivated protein kinase pathway (5, (7) (8) (9) (10) . LPA also stimulates a PTX-insensitive pathway resulting in actin rearrangement and stress fiber formation in fibroblast cells. This effect is known to be mediated by the small GTPase Rho, which is thought to function downstream of G protein stimulation (2, 6) . This pathway also has been reported for LPA-induced neurite retraction associated with actin rearrangement in neuronal cell lines (11) . Rho has been implicated further in cell cycle progression (12) and may also affect cell proliferation through activation of serum response elements (SREs) (4) .
Recent studies have identified genes for at least two divergent, functional, G protein-coupled LPA receptors from mammals (13) or frogs (14) ; it is probable that other related but distinct receptors also exist (T. Hla, personal communication). This probability raises the formal possibility that the diverse effects produced by LPA could be accounted for by a combination of nonreceptor mechanisms with multiple, uni-functional receptors on a single cell, rather than a single, multifunctional receptor. Here, we analyze the function of ventricular zone gene-1 (vzg-1) (also referred to as lp A1 ͞edg-2), which encodes a mammalian G protein-coupled LPA receptor (13) , in mediating LPAdependent responses by using a heterologous expression system consisting of two cell lines from either a neuronal or nonneuronal lineage that neither expresses vzg-1 nor responds to LPA.
EXPERIMENTAL PROCEDURES
Lipids, Vectors, and C3 Exoenzyme. Oleoyl-LPA, lysophosphatidic choline, lysophosphatidic ethanolamine, lysophosphatidic glycerol, and phosphatidic acid were purchased from Avanti Polar Lipids (Alabaster, AL). Expression vectors used in this study are summarized in Table 1 . C3 exoenzyme was expressed in Escherichia coli as recombinant protein (his-C3 exoenzyme) tagged with hexahistidine at the N terminus and purified by using Nickel-agarose (Qiagen) and CM-Sepharose CL-6B (Sigma) up to 95% homogeneity on SDS͞PAGE, and its function was confirmed by the [ 32 P]-ADP ribosylation assay (11, 15) . Cell Culture, Transfection, [
35 S]-Methionine͞Cysteine Labeling, and Immunoprecipitation. RH7777 and B103 cells were maintained in DMEM (GIBCO͞BRL) containing 10% fetal calf serum. Transient transfection used a DNA͞lipofectoamine (GIBCO͞BRL) complex (15 h) grown in fresh serum-free DMEM (30 h) and then assayed. Stable transfection of B103 cells used co-transfection with control or experimental vector and pSV-neo for selection by calcium phosphate (13) . Stable cell lines were serum-starved for 24 h before assay (summarized in Table  1 ).
For detection of VZG-1 exogenously expressed, RH7777 cells were labeled with 50 Ci͞ml of [ 35 S]-methionine͞cysteine (1,175 Ci͞mmol, NEN) in methionine͞cysteine-free DMEM for 6 h. The cells were lysed with 50 mM Tris⅐HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 1% (wt͞vol) Triton X-100, 0.5% deoxycholate-Na, and protease inhibitor mixture (Calbiochem), immunoprecipitated with anti-flag M2 antibody (Kodak), followed by protein G-agarose chromatography, and analyzed by SDS͞PAGE and then fluorography by using Amplify (Amersham). In some experiments, cells were treated with 200 ng͞ml PTX (Sigma) for 18 h or 30 g͞ml his-C3 exoenzyme for 24 h in serum-free medium before membrane preparation or LPA application to cells. In the bromodeoxyuridine (BrdU) incorporation assay, toxin was re-added to cultures when LPA was applied. S]-GTP␥S as described above. To stop the reaction, 40 l of 110 M GTP was added, and the mixtures were centrifuged at 15,000 ϫ g for 20 min at 4°C. The resulting pellet was solubilized in 50 mM Tris⅐HCl (pH 7.5) containing 150 mM NaCl, 5 mM MgCl 2 , 0.6% Nonidet P-40, 1 mM EDTA, 1 mM DTT, and protease inhibitor cocktail. After centrifugation at 15,000 ϫ g for 20 min at 4°C, the supernatant was incubated with anti-G ␣i3 antibody (recognizing G ␣i1 and G ␣i2 less than G ␣i3 , Santa Cruz Biotechnology) for 15 h, followed by the incubation with protein G-agarose for 1 h at 4°C. Agarose beads were washed and counted by liquid scintillation.
Functional Assays. For stress fiber formation assay, RH7777 cells (3,000 cells͞cm 2 ) were seeded on coverslips pre-coated with Cell-Tak (2 g, Collaborative Research) and transfected. Cells were treated without or with ligand for 15 min, fixed with 4% paraformaldehyde, and permeabilized with 0.1% Triton X-100 in PBS for 30 min. Flag was visualized by anti-flag M2 antibody (0.5 g͞ml) and indirect immunofluorescence (fluorescein isothiocyanate, Vector Labs). Actin was labeled with tetramethylrhodamine isothiocyanate (TRITC)-labeled phalloidin (0.2 g͞ml, Sigma). Cells were observed by using a Zeiss fluorescence microscope. For neurite retraction assay, cells were treated without or with ligand for 30 min, fixed with 4% paraformaldehyde, and counted by using a Zeiss inverted microscope.
For chloramphenicol acetyltransferase (CAT) induction assay, clone C-1, a stable B103 cell line containing CAT under SRE control, was transfected, exposed to LPA in 0.1% fatty acid-free BSA between 40 and 48 h after transfection, and subjected to CAT ELISA (Boehringer Mannheim). For BrdU incorporation assay, cells were treated with LPA in 0.1% fatty acid-free BSA for 24 h, and then BrdU at 40 M was added for the last 1 h. Cells were subjected to BrdU immunostaining (Boehringer Mannheim kit).
RESULTS
Two vzg-1-Null Cell Lines Are Unresponsive to LPA Stimulation. Our previous finding that there is little or no expression of vzg-1 in liver nor neural expression outside of the embryonic cerebral cortex (13) led to identification of a hepatoma cell line, RH7777 (17) , and a noncortical neuroblastoma cell line, B103 (18) . Northern blot analysis (Fig. 1A) as well as reverse transcriptase PCR analysis (data not shown) demonstrated that these cell lines did not express vzg-1. In addition, these cells were not responsive to concentrations of LPA up to 1 M, based on the multiple biochemical and morphological assays used in this study. These cell lines thus provide a heterologous expression system for the analysis of VZG-1 function.
Epitope-Tagged VZG-1 Is Expressed and Increases 3 H-LPA Membrane Binding. To demonstrate that a functional VZG-1, LPA receptor was being expressed, ligand binding experiments were performed by using isolated membranes from RH7777 cells transiently transfected with either pflag (control vector; see Table  1 for constructs used) or pflag͞vzg-1. Only cells expressing pflag͞vzg-1 showed increases in specific [ 1-transfected cells increased over 70% after LPA exposure in a dose-dependent manner (Fig. 2 A) .
A similar response also was observed by using [ 35 (Fig.  2C) . The stimulatory effects of LPA on [ 35 S]-GTP␥S binding were not mimicked by structurally related compounds (Fig. 2D) .
When [
35 S]-GTP␥S binding was combined with immunoprecipitation by using various anti-G protein antibodies including anti-G ␣i1,2 , anti-G ␣i3 , anti-G ␣o , anti-G ␣q͞11 , and anti-G ␣13 , only the anti-G ␣i3 antibody was useful for immunoprecipitation, reflecting a combination of antibody properties, expression level of endogenous G proteins, and͞or the lower stoichiometry of some G proteins (e.g., G 13 ) vs. G i for GTP␥S (25, 26) . LPA increased [ 35 S]-GTP␥S binding in the immunoprecipitates with anti-G ␣i3 antibody from S-3, over A-5 (Fig. 2E) , confirmed by Western blot of the labeled protein (data not shown), indicating that VZG-1 directly coupled to G i . Although we could not demonstrate direct coupling of VZG-1 to other G proteins, Western blot analysis of the cell lines showed that G proteins thought to be involved in LPA signaling were expressed in control B103 and RH7777 cell lines, although the latter did not express G o (Fig. 2F) . These results indicated that the employed cell lines contained G proteins that have been implicated in LPA signaling and that VZG-1 directly couples to G i .
Stress Fiber Formation Is Dependent on VZG-1 Expression and LPA Stimulation. A major effect of LPA is actin rearrangement, including stress fiber formation consisting of actin filaments (F-actin) that can be detected by fluorescently labeled phalloidin. RH7777 cells were remarkable for their lack of stress fiber formation either before or after exposure to LPA (up to 1 M) or serum (data not shown). However, these cells did have the ability to form stress fibers when constitutively activated Rho was overexpressed in the cells (data not shown). When RH7777 cells (n ϭ 3) . ‫,ء‬ P Ͻ 0.05 (using Student's t test) vs. no LPA. (F) Western blot demonstrates expression of G proteins thought to mediate LPA signaling in mouse brain, B103, and RH7777 cell lines. Isolated membranes (50 g) were subjected to Western blotting, as described (13) . See Table 1 and Experimental Procedures for abbreviations.
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Proc. Natl. Acad. Sci. USA 95 (1998) were transfected transiently with the control (pflag), the pattern of actin-staining with TRITC-phalloidin was diffuse throughout cells as seen with untransfected cells (Fig. 3A) and was unaffected by LPA exposure (Fig. 3B) . By contrast, cells transfected with pflag͞vzg-1 were immunostained specifically by anti-flag antibody (Fig. 3C) , and phalloidin labeling in these cells was always more intense than that in untransfected cells (Fig. 3D) . Indeed, a small percentage of VZG-1-expressing cells showed stress fibers in the absence of LPA. However, when 100 nM LPA was added to cultures of VZG-1-expressing cells, dramatic stress fibers were observed in flag-positive cells (Fig. 3 E and F) . Stress fiber formation after LPA exposure was dose-dependent (EC 50 ϭ 4 nM; Fig. 3G ). Similar results were obtained by using another expression vector, pHook2͞vzg-1 (data not shown, but see Fig. 5 ), indicating that LPA-dependent responses were not caused by the expression vector per se. To determine whether LPA-stimulated VZG-1 activates stress fiber formation through Rho, C3 exoenzyme, which ADP ribosylates and inactivates Rho, was used (11, 15, 27, 28) . When RH7777 cells expressing VZG-1 were preincubated with functional recombinant his-C3 exoenzyme and stained with TRITC-labeled phalloidin, stress fiber formation was limited to control levels and was unaffected by LPA stimulation (Fig. 3G ). Stress fiber formation by LPA was not reproduced by other lysophosphatidic compounds or phosphatidate (Fig. 3H) , consistent with previous data (13) . Thus, activated Rho is involved in VZG-1-dependent stress fiber formation after LPA stimulation. Neurite Retraction Is Dependent on VZG-1 Expression and LPA Stimulation and Also Is Mediated by Rho. Contrasting with cells from mesenchymal lineage such as fibroblasts, cells of neuronal lineage that respond with cytoskeletal changes to LPA do not form stress fibers but rather change their morphology by retracting neurites and producing a cell of spherical appearance (''cell rounding''; refs. 11 and 13). The majority of control B103 cells (as well as sense S-3 and antisense A-5) have long processes when grown under serum-free conditions (Fig. 4 A, C, and E) . This morphology remained unchanged after control B103 or A-5 cells were exposed to LPA (up to 1 M; Fig. 4 B and D) . In sharp contrast, S-3 cells retracted neurites after LPA exposure (Fig.  4G) , accompanied by actin rearrangement, based on staining with TRITC-phalloidin (data not shown). The same response to LPA was observed with two other independent sense clones, S-4 and S-7, and the effect was dose-dependent (1 nM-1 M ; Fig.  4G ); the EC 50 was 4, 4, and 2 nM for S-3, S-4, and S-7, respectively. His-C3 exoenzyme but not PTX prevented the retraction of neurites by LPA, indicating that VZG-1 mediates neurite retraction by LPA through activated Rho in cells of neuronal lineage (Fig. 4H) . A and B) or pflag͞vzg-1 (C to E) and then exposed to LPA at 0 nM (A, C, and D) or 100 nM (B, E, and F) for 15 min. Cells were fixed and double-labeled for flag-epitope (using M2 antibody visualized by indirect immunofluorescence using fluorescein isothiocyanate; C and E) and actin (visualized with TRITC-phalloidin; A, B, D, and F). Note that stress fibers are observed only with VZG-1 expression and LPA exposure (E and F). Arrowheads, nontransfected cells. (Bar ϭ 10 m. ) (G) Effect of his-C3 exoenzyme on LPA-induced stress fiber formation in VZG-1-expressing cells. RH7777 cells transfected with pflag͞vzg-1 were treated without or with his-C3 exoenzyme, exposed to varying concentrations of LPA, and double-labeled for flag epitope and actin. The change in the number of double-labeled cells with stress fibers after LPA exposure compared with control (no LPA) was expressed as ''fold increase.'' Data are the mean Ϯ SEM (n ϭ 4). ‫,ء‬ P Ͻ 0.05 (using Student's t test) vs. no LPA. #, P Ͻ 0.05 vs. no C3 exoenzyme. (H) Effect of structurally related phospholipids on VZG-1-mediated stress fiber formation in pflag͞vzg-1-transfected RH7777 cells. Data are the mean Ϯ SEM (n ϭ 3). ‫,ء‬ P Ͻ 0.05 (using Student's t test) vs. no LPA. See Experimental Procedures for abbreviations.
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Cell Biology: Fukushima et al. Proc. Natl. Acad. Sci. USA 95 (1998) been shown to activate the c-fos SRE (3, 4) . To investigate whether VZG-1 can mediate LPA stimulation of SREs, B103 cells stably expressing CAT under c-fos SRE regulation (cell line C-1) were used to examine the effects of VZG-1 expression. LPA increased CAT protein expression only in pHook2͞vzg-1-transfected cells in a dose-dependent manner (Fig. 5A) . SRE activation by VZG-1 expression and LPA exposure was blocked completely by either pretreatment with PTX or his-C3 exoenzyme (Fig. 5A ). Mitogenic effects of LPA, determined by BrdU incorporation, were observed in a vzg-1 sense clone, S-3 ( Fig. 5B) but not in control B103 nor A-5 (data not shown). The increase in BrdU incorporation by LPA was blocked completely by pretreatment of cells with PTX (Fig. 5B) . In addition, his-C3 exoenzyme partially inhibited these LPA effects (Fig. 5B) . These data indicate that VZG-1 is a receptor for LPA that mediates both SRE activation and a subsequent event, cell cycle progression, through the G i ͞G o and Rho pathways.
DISCUSSION
A wide range of biological activities in a variety of neural and nonneural cell types has been documented for LPA (6) . However, whether these activities were mediated by a single LPA receptor, several distinct receptors, or nonreceptor mechanisms has been unclear. In this study, we have made use of heterologous expression of VZG-1, a functional mammalian LPA receptor (13) . Heterologous VZG-1 expression mediates at least six previously reported biological responses to LPA, including the production of demonstrate that a single G protein-coupled receptor, VZG-1, is necessary and sufficient for mediating multiple effects produced by LPA stimulation. It signals through at least two distinct pathways-a G i ͞G o pathway and a PTX-insensitive pathway that involves Rho activation-in vzg-1 null cell lines from both a neuronal and nonneuronal lineage (Fig. 6) .
LPA has been implicated in the activation of several G proteins that have been defined by their sensitivity-or lack of sensitivity-to PTX (1, 7, 10, 29-31 ). The PTX-sensitive response has indicated the involvement of G i and͞or G o , activation of the former producing inhibition of adenylyl cyclase (1, 10, 31) . We have shown previously that VZG-1 mediates inhibition of adenylyl cyclase by LPA in cortical neuroblast cell lines (13) . Present data from the [ 35 S]-GTP␥S labeling (Fig. 2 C and E) demonstrate that, indeed, G i couples directly with VZG-1 after LPA exposure. At the same time, VZG-1 also mediates actin-based cytoskeletal changes that operate through a PTX-insensitive, but Rhosensitive, pathway, but does so with phenotypically different results depending on the lineage of the cells examined (stress fiber formation in nonneuronal cells vs. neurite retraction and cell rounding in neuronal cell lines). The mechanisms responsible for this difference must be downstream of Rho activation in view of the effects of C3 exoenzyme.
Activation of SRE-dependent transcription is regulated by several proteins, including serum response factor and ternary complex factor (32) . Stimulation of Ras-Raf-mitogen-activated protein kinase cascade links to SRE activation through ternary complex factor (33) , and Rho mediates SRE activation through signaling to serum response factor (4). Our data indicate that VZG-1 activation by LPA increases transcription through exogenous SREs via both G i ͞G o and Rho pathways, based on decreased reporter gene expression by either functional PTX or C3 exoenzyme. This result is consistent with data showing that LPA-induced c-fos transcription is mediated by both Rho (4) as well as G i2 (5) . Thus, VZG-1 transduces LPA signals into the same DNA target through two separate pathways. This overlap may reflect differences in the levels of upstream pathway activation and͞or downstream gene transcription that result in a spectrum of cellular responses.
One important response that can be related to SRE activation is progression of the cell cycle. Indeed, VZG-1 also mediated mitogenic effects of LPA, which are blocked by either PTX or C3 exoenzyme, similar to SRE activation. These data are consistent further with the dual-pathway stimulation of SREs noted above and the roles of both G i (1, 10, 34) , and Rho (12, 15, 35) in stimulating DNA synthesis and cell growth.
From the presented data and independent studies with mammalian cells (36) and yeast (37) , a single LPA receptor, VZG-1͞ LP A1 ͞EDG-2, is capable of mediating multiple cellular responses by LPA in both neuronal and nonneuronal cells to regulate cell morphology and growth. Such multifunctional potential, for cells from different lineages, suggests biological consequences that, in the absence of specific LPA antagonists, may be discernible through molecular genetic approaches. In addition, the use of similar heterologous expression approaches should be useful in determining the role of nonreceptor mechanisms and receptor mechanisms mediated by other related receptors. As the first identified member of a growing family of homologous lysophospholipid receptor genes (J.C., J.J.A.C., and D.M., unpublished work), vzg-1 provides an archetypal model for how receptors for other lipids, including sphingosine-1-phosphate and lysosphingomyelin, mediate cell signaling (38) . 
